CU

Christoph Uherek

BA Biotest Ag: 14 patents #2 of 62Top 4%
IM Immunogen: 5 patents #34 of 119Top 30%
GG Ganymed Pharmaceuticals Gmbh: 5 patents #17 of 49Top 35%
JM Johannes Gutenberg-Universität Mainz: 3 patents #17 of 93Top 20%
AP Astellas Pharma: 2 patents #350 of 954Top 40%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
Overall (All Time): #205,922 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11739139 Monoclonal antibodies against Claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2023-08-29
10738108 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2020-08-11
10174104 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2019-01-08
10117932 Uses of immunoconjugates targeting CD138 Gregor Schulz, Frank Osterroth, Thomas Haeder, Christoph Bruecher, Gabriele Niemann +7 more 2018-11-06
10017564 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2018-07-10
9995733 Agents for treating disease Frank Osterroth, Christoph Bruecher, Benjamin Daelken, André Engling, Chantal Zuber +4 more 2018-06-12
9751934 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2017-09-05
9605066 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Bruecher, Peter Röttgen, Benjamin Daelken, André Engling +5 more 2017-03-28
9550831 Method for treating psoriasis Silke Aigner, Matthias Germer, Frank Osterroth, Elmar Kraus, Andrea Wartenberg-Demand +6 more 2017-01-24
9540436 Use of antibodies for detection of IL-10 Frank Osterroth, Christoph Bruecher, Peter Röttgen, Benjamin Daelken, André Engling +2 more 2017-01-10
9512226 Agent for treating disease Matthias Germer, Frank Osterroth, Silke Aigner, Elmar Kraus, Andrea Wartenberg-Demand +6 more 2016-12-06
9499609 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2016-11-22
9446146 Methods and agents for improving targeting of CD138 expressing tumor cells Benjamin Daelken, Kenneth C. Anderson, Teru Hideshima, Christoph Bruecher, Frank Osterroth +2 more 2016-09-20
9387261 Immunoconjugates targeting CD138 and uses thereof Elmar Kraus, Christoph Bruecher, Benjamin Daelken, Steffen Zeng, Frank Osterroth +4 more 2016-07-12
9334325 Method for treating psoriasis Frank Osterroth, Silke Aigner, Matthias Germer, Elmar Kraus, Andrea Wartenberg-Demand +5 more 2016-05-10
9289509 Uses of immunoconjugates targeting CD138 Frank Osterroth, Christoph Bruecher, Benjamin Daelken, André Engling, Thomas Haeder +7 more 2016-03-22
9221914 Agents targeting CD138 and uses thereof Elmar Kraus, Christoph Bruecher, Benjamin Daelken, Matthias Germer, Steffen Zeng +3 more 2015-12-29
9212228 Monoclonal antibodies against claudin-18 for treatment of cancer Ugur Sahin, Ozlem Tureci, Dirk Usener, Stefan Fritz, Gunda Brandenburg +3 more 2015-12-15
9011864 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates Gregor Schulz, Christoph Bruecher, Frank Osterroth, Steffen Zeng, Silke Aigner +3 more 2015-04-21
8956607 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Bruecher, Peter Röttgen, Benjamin Daelken, André Engling +2 more 2015-02-17
8852871 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Bruecher, Peter Röttgen, Benjamin Daelken, André Engling +5 more 2014-10-07